BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib

Blood Adv. 2023 Jul 25;7(14):3378-3381. doi: 10.1182/bloodadvances.2022009366.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Humans
  • Imidazoles
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Mutation
  • Pyrimidines / therapeutic use

Substances

  • tirabrutinib
  • Pyrimidines
  • Imidazoles